Herceptin News
Most Popular Herceptin Story
FDA rewards Roche with priority review for blockbuster cancer drug
After racking up a solid set of late-stage data on the experimental breast cancer drug pertuzumab late last year, Roche ($RHHBY) and Genentech scored priority review status for the program, shaving Read more...
Latest Headlines
- February 8, 2012
- December 8, 2011
- February 11, 2011
- July 9, 2008
- May 21, 2008
- October 12, 2007
- January 9, 2007
- August 14, 2006
- February 16, 2006
- December 22, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
